Nas­daq wraps up Q3 with IPO pitch­es from Gami­da Cell, NGM, Arog to­talling $219M

Nas­daq’s bub­bling biotech week did not just end with Gri­s­tone’s top-of-the-range raise, which brought the IPO tal­ly to $520 mil­lion. Late Fri­day, three more biotechs …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER